Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Tuesday, United States Antimony’s Director, Joseph A. Carrabba, made a $100,536 buy of UAMY, purchasing 21,300 shares at a cost of $4.72 a piece. Carrabba was up about 15.0% on the purchase at the high point of today’s trading session, with UAMY trading as high as $5.43 in trading on Friday. United States Antimony is trading up about 1.9% on the day Friday. This buy marks the first one filed by Carrabba in the past twelve months.

And at Pulse Biosciences, there was insider buying on Tuesday, by Chief Operating Officer Liane Rae Teplitsky who bought 2,025 shares for a cost of $49.37 each, for a total investment of $99,971. Before this latest buy, Teplitsky made one other buy in the past twelve months, purchasing $99,965 shares for a cost of $48.29 each. Pulse Biosciences is trading down about 1.7% on the day Friday. So far Teplitsky is in the green, up about 10.9% on their purchase based on today’s trading high of $54.75.

VIDEO: Friday 9/4 Insider Buying Report: UAMY, PLSE